B cells: From the bench to the clinical practice

Acta Reumatologica Portuguesa

Volumn 33, Issue 2, 2008, Pages 137-154

  Moura, Rita ^a   Água Doce, Ana ^a   Weinmann, Pamela ^a   Graça, Luís ^a   Fonseca, João Eurico ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Antibody; Autoimmunity; B cells; Bone marrow; Tolerance

Indexed keywords

ANTIGEN;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANTIBODY FORMATION; ANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; LYMPHOCYTE ACTIVATION;

EID: 53749095047     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (216)

1. Glick B., The bursa of Fabricius and immunoglobulin synthesis. Int Rev Cytol, 1977. 48: p. 345-402.
2. Cooper, M.D., et al., The functions of the thymus system and the bursa system in the chicken. J Exp Med, 1966. 123(1): p. 75-102.
3. Nunez, C., et al., B cells are generated throughout life in humans. J Immunol, 1996. 156(2): p. 866-872.
4. Loken, M.R., et al., Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development Blood, 1987. 70(5): p. 1316-1324.
5. LeBien, T.W., et al., Multiparameter (low cytometric analysis of human fetal bone marrow B cells. Leukemia, 1990. 4(5): p. 354-358.
6. Rossi, M.I., et al., B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood, 2003. 101(2): p. 576-584.
7. Hystad, M.E, et al., Characterization of early stages of human B cell development by gene expression profiling. J Immunol, 2007. 179(6): p. 3662-3671.
8. Li, Y.S., et al., Identificafion of the earliest B lineage stage in mouse bone marrow. Immunity, 1996. 5(6): p. 527-535.
9. Tudor, K.S., et al., Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events. Immunity, 2000. 12(3): p. 335-345.
10. Johnson, S.E., et al., Murine and human IL-7 activate STAT5 and induce proliferation of normal human pro-B cells. J Immunol, 2005. 175(11): p. 7325-7331.
11. Taguchi, T., et al., Interleukin-7 contributes to human pro-B-cell development in a mouse stromal cell-dependent culture system. Exp Hematol, 2007. 35(9): p. 1398-1407.
12. Kline, G.H., et al., Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains. J Immunol, 1998. 161(4): p. 1608-1618.
13. Hardy, R.R., et al., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med, 1991. 173(5): p. 1213-1225.
14. Rolink, A., et al., IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol, 1994. 6(8): p. 1257-1264.
15. Ghia, P., et al., Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J Exp Med, 1996. 184(6): p. 2217-2229.
16. Karasuyama, H., et al., The expression of VpreB/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell, 1994. 77(1): p. 133-143.
17. Ghia, P., et al., Immature B cells from human and mouse bone marrow can change their surface light chain expression. Eur J Immunol, 1995. 25(11): p. 3108-3114.
18. Moe, R.E., Electron Microscopic Appearance of the Parenchyma of Lymph Nodes. Am J Anat, 1964. 114: p. 341-369.
19. Crivellato, E., A. Vacca, and D. Ribatti, Setting the stage: an anatomist's view of the immune system. Trends Immunol, 2004. 25(4): p. 210-217.
20. Okada, T., et al., Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med, 2002. 196(1): p. 65-75,
21. Ebisuno, Y., et al., Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J Immunol, 2003. 171(4): p. 1642-1646.
22. Kanemitsu, N., et al., CXCL13 is an arrest chemokine for B cells in high endothelial venules. Blood, 2005. 106(8): p. 2613-2618.
23. Garside, P., et al., Visualization of specific B and T lymphocyte interactions in the lymph node. Science, 1998. 281(5373): p. 96-99.
24. Weiss, L., The structure of fine splenic arterial vessels in relation to hemoconcentration and red cell destruction. Am J Anat, 1962. 111: p. 131-179.
25. Weiss, L., A scanning electron microscopic study of the spleen. Blood, 1974. 43(5): p. 665-691.
26. Steiniger, B., P. Barth, and A. Hellinger, The perifollicular and marginal zones of the human splenic white pulp: do fibroblasts guide lymphocyte immigration? Am J Pathol, 2001. 159(2): p. 501-512.
27. Cornes, J.S., Peyer's patches in the human gut. Proc R Soc Med, 1965. 58(9): p. 716.
28. Owen, R.L. and A.L Jones, Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology, 1974. 66(2): p. 189-203.
29. Farstad, I.N., et al., Heterogeneity of M-cell-associated B and T cells in human Peyer's patches. Immunology, 1994. 83(3): p. 457-464.
30. Islam, K.B., et al., TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol, 1991. 3(11): p. 1099-1106.
31. Nilsson, L., et al., Structure of TGF-beta 1-induced human immunoglobulin C alpha 1 and C alpha 2 germ-line transcripts. Int Immunol, 1991. 3(11): p. 1107-1115.
32. Crabbe, P.A. and J.F. Heremans, The distribution of immunoglobulin-containing cells along the human gastrointestinal tract. Gastroenterology 1968. 54(4): p. 822, 825.
33. Crago, S.S., et al., Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol, 1984. 132(1): p. 16-18.
34. MacLennan, I.C., Germinal centers. Annu Rev Immunol, 1994. 12: p. 117-139.
35. Allen, C.D., et al., Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol, 2004. 5(9): p. 943-952.
36. van den Oord, J.J., C. de Wolf-Peeters, and V.J. Desmet, The composite nodule. A structural and functional unit of the reactive human lymph node. Am J Pathol, 1986. 122(1): p. 83-91.
37. Tierens, A., et al., Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood, 1999. 93(1): p. 226-234.
38. Berek, C., A. Berger, and M. Apel, Maturation of the immune response in germinal centers. Cell, 1991. 67(6): p. 1121-1129.
39. Han, S., et al., Distinctive characteristics of germinal center B cells. Semin Immunol, 1997. 9(4): p. 255-260.
40. Camacho, S.A., M.H. Kosco-Vilbois, and C. Berek, The dynamic structure of the germinal center. Immunol Today, 1998. 19(11): p. 511-514.
41. Husson, H., et al., Functional effects of TNF and lymphotoxin alpha1beta2 on FDC-like cells. Cell Immunol, 2000. 203(2): p. 134-143.
42. Lindhout, E., et al., Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol, 1993. 91(2): p. 330-336.
43. Barone, F., et al., Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum, 2005. 52(6): p. 1773-1784.
44. Gunn, M.D., et al., A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature, 1998. 391(6669): p. 799-803.
45. Breitfeld, D., et al., Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med, 2000. 192(11): p. 1545-1552.
46. Han, S., et al., In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med, 1995. 182(6): p. 1635-1644.
47. Surh, C.D. and J. Sprent, T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 1994. 372(6501): p. 100-103.
48. Baumann, I., et al., Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum, 2002. 46(1): p. 191-201.
49. Gaipl, U.S., et al., Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev, 2005. 4(4): p. 189-194.
50. Arce, S., et al., CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations. J Leukoc Biol, 2004. 75(6): p. 1022-1028.
51. Vora, K.A., K. Tumas-Brundage, and T. Manser, Contrasting the in situ behavior of a memory B cell clone during primary and secondary immune responses. J Immunol, 1999. 163(8): p. 4315-4327.
52. Caligaris-Cappio, F., et al., Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med, 1982. 155(2): p. 623-628.
53. Hayakawa, K., et al., Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A, 1984. 81(8): p. 2494-2498.
54. Hayakawa, K., et al., Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med, 1985. 161(6): p. 1554-1568.
55. Hardy, R.R. and K. Hayakawa, Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immunol Rev, 1986. 93: p. 53-79.
56. Rothstein, T.L., Cutting edge commentary: two B-1 or not to be one. J Immunol, 2002. 168(9): p.4257-4261.
57. Bos, N.A., et al., The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. Cell Immunol, 1988. 112(2): p. 371-380.
58. Mackenzie, L.E., et al., Auto- and polyreactivity of IgM from CD5+ and CD5-cord blood B cells. Scand J Immunol, 1991. 33(3): p. 329-335.
59. Haas, K.M., et al., B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity, 2005. 23(1): p. 7-18.
60. Alugupalli, K.R., et al., B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity, 2004. 21(3): p. 379-390.
61. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind, Identification of a B-1 B cell-specified progenitor. Nat Immunol, 2006. 7(3): p. 293-301.
62. Boumsell, L., et al., Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol, 1978. 8(12): p. 900-904.
63. Kasaian, M.T., H. Ikematsu, and P. Casali, Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J Immunol, 1992. 148(9): p. 2690-2702.
64. Morikawa, K., F. Oseko, and S. Morikawa, Induction of CD5 antigen on human CD5-B cells by stimulation with Staphylococcus aureus Cowan strain I. Int Immunol, 1993. 5(8): p. 809-816.
65. Wortis, H.H., et al., B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A, 1995. 92(8): p. 3348-3352.
66. Hieter, P.A., et al., Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature, 1981. 290(5805): p. 368-372.
67. Hozumi, N. and S. Tonegawa, Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci U S A, 1976. 73(10): p. 3628-3632.
68. Tonegawa, S., Somatic generation of antibody diversity. Nature, 1983. 302(5909): p. 575-581.
69. Papavasiliou, F., et al., V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science, 1997. 278(5336): p. 298-301.
70. Oettinger, M.A., et al., RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science, 1990. 248(4962): p. 1517-1523.
71. McBlane, J.F., et al., Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell, 1995. 83(3): p. 387-395.
72. Grawunder, U., et al., Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 1995. 3(5): p. 601-608.
73. Difilippantonio, M.J., et al., RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination. Cell, 1996. 87(2): p. 253-262.
74. Sawchuk, D.J., et al., V(D)J recombination: modulation of RAG1 and RAG2 cleavage activity on 12/23 substrates by whole cell extract and DNA-bending proteins. J Exp Med, 1997. 185(11): p. 2025-2032.
75. Hiom, K. and M. Gellert, A stable RAG1-RAG2-DNA complex that is active in V(D)J cleavage. Cell, 1997. 88(1): p. 65-72.
76. Constantinescu, A. and M.S. Schlissel, Changes in locus-specific V(D)J recombinase activity induced by immunoglobulin gene products during B cell development. J Exp Med, 1997. 185(4): p. 609-620.
77. Girschick, H.J., et al., RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood. J Immunol, 2001. 166(1): p. 377-386.
78. Zhang, Z., et al., Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue. Arthritis Rheum, 2001. 44(10): p. 2275-2284.
79. Girschick, H.J., et al., Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum, 2002. 46(5): p. 1255-1263.
80. Mombaerts, P., et al., RAG-1-deficient mice have no mature B and T lymphocytes. Cell, 1992. 68(5): p. 869-877.
81. Shinkai, Y., et al., RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell, 1992. 68(5): p. 855-867.
82. Notarangelo, L.D., A. Villa, and K. Schwarz, RAG and RAG defects. Curr Opin Immunol, 1999. 11(4): p. 435-442.
83. Early, P., et al., An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell, 1980. 19(4): p. 981-992.
84. Eastman, Q.M., T.M. Leu, and D.G. Schatz, Initiation of V(D)J recombination in vitro obeying the 12/23 rule. Nature, 1996. 380(6569): p. 85-88.
85. Desiderio, S.V., et al., Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature, 1984. 311(5988): p. 752-755.
86. Gilfillan, S., et al., Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science, 1993. 261(5125): p. 1175-1178.
87. Benedict, C.L., S. Gilfillan, and J.F. Kearney, The long isoform of terminal deoxynucleotidyl transferase enters the nucleus and, rather than catalyzing non-templated nucleotide addition, modulates the catalytic activity of the short isoform. J Exp Med, 2001. 193(1): p. 89-99.
88. Papavasiliou, F.N. and D.G. Schatz, Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature, 2000. 408(6809): p. 216-221.
89. Bross, L., et al., DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation. Immunity, 2000. 13(5): p. 589-597.
90. Bemark M., et al., Somatic hypermutalion in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med, 2000. 192(10): p. 1509-1514.
91. Goossens, T., U. Klein, and R. Kuppers, Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A, 1998. 95(5): p. 2463-2468.
92. Wilson, P.C., et al., Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med, 1998. 187(1): p. 59-70.
93. Sale, J.E. and M.S. Neuberger, TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 1998. 9(6): p. 859-869.
94. Du Pasquier, L., The phylogenetic origin of antigen-specific receptors. Curr Top Microbiol Immunol, 2000. 248: p. 160-185.
95. Muramatsu, M., et al., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 2000. 102(5): p. 553-563.
96. Revy, P., et al., Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell, 2000. 102(5): p. 565-575.
97. Okazaki, I.M., et al., The AID enzyme induces class switch recombination in fibroblasts. Nature, 2002. 416(6878): p. 340-345.
98. Iwasato, T., et al., Circular DNA is excised by immunoglobulin class switch recombination. Cell, 1990. 62(1): p. 143-149.
99. Muramatsu, M., et al., Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem, 1999. 274(26): p. 18470-18476.
100. Chaudhuri, J., et al., Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature, 2003. 422(6933): p. 726-730.
101. Ta, V.T., et al., AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol, 2003. 4(9): p. 843-848.
102. Hombach, J., et al., Molecular components of the B-cell antigen receptor complex of the IgM class. Nature, 1990. 343(6260): p. 760-762.
103. Kurosaki, T., et al., Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J Exp Med, 1995. 182(6): p. 1815-1823.
104. Pao, L.I., S.J. Famiglietti, and J.C. Cambier, Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction. J Immunol, 1998. 160(7): p. 3305-3314.
105. Flaswinkel, H. and M. Reth, Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. Embo J, 1994. 13(1): p. 83-89.
106. Li, C., et al., Cooperative interaction of Ig(alpha) and Ig(beta) of the BCR regulates the kinetics and specificity of antigen targeting. Int Immunol, 2002. 14(10): p. 1179-1191.
107. Sato, S., et al., Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol, 1997. 159(7): p. 3278-3287.
108. Mongini, P.K., et al., Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. J Immunol, 2003. 171(10): p. 5244-5254.
109. Cherukuri, A., et al., The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol, 2004. 172(1): p. 370-380.
110. Kurosaki, T., et al., Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med, 1994. 179(5): p. 1725-1729.
111. Saito, K., A.M. Scharenberg, and J.P. Kinet, Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J Biol Chem, 2001. 276(19): p. 16201-16206.
112. Fu, C., et al., BLNK: a central linker protein in B cell activation. Immunity, 1998. 9(1): p. 93-103.
113. Takata, M., et al., Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. Embo J, 1994. 13(6): p. 1341-1349.
114. Saijo, K., et al., Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J Exp Med, 2002. 195(12): p. 1647-1652.
115. Dolmetsch, R.E., et al., Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature, 1997. 386(6627): p. 855-858.
116. Smith, K.G., et al., Inhibition of the B cell by CD22: a requirement for Lyn. J Exp Med, 1998. 187(5): p. 807-811.
117. Bobbitt, K.R. and L.B. Justement, Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22. J Immunol, 2000. 165(10): p. 5588-5596.
118. Otipoby, K.L., K.E. Draves, and E.A. Clark, CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J Biol Chem, 2001. 276(47): p. 44315-44322.
119. Latour, S., W.H. Fridman, and M. Daeron, Identification, molecular cloning, biologic properties, and tissue distribution of a novel isoform of murine low-affinity IgG receptor homologous to human Fc gamma RIIB1. J Immunol, 1996. 157(1): p. 189-197.
120. Bolland, S. and J.V. Ravetch, Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity, 2000. 13(2): p. 277-285.
121. Lang, P., et al., TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers. Science, 2001. 291(5508): p. 1537-1540.
122. Poudrier, J. and T. Owens, CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med, 1994. 179(5): p. 1417-1427.
123. Nabavi, N., et al., Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature, 1992. 360(6401): p. 266-28.
124. Freeman, G.J., et al., Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science, 1993. 262(5135): p. 909-911.
125. Watts, T.H., et al., Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction. J Immunol, 1993. 150(6): p. 2192-2202.
126. Aluvihare, V.R., et al., Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction. Embo J, 1997. 16(12): p. 3553-3562.
127. Cheng, P.C., et al., MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens. J Immunol, 1999. 162(12): p. 7171-7180.
128. Okada, T., et al., Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol, 2005. 3(6):p. e150.
129. Evans, D.E., et al., Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J Immunol, 2000. 164(2): p. 688-697.
130. Wu, Y., et al., Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol, 1995. 5(11): p. 1303-1311.
131. Nishioka, Y. and P.E. Lipsky, The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol, 1994. 153(3): p. 1027-1036.
132. Grewal, J.S., J. Xu, and R.A. Flavell, Impairment of antigen-specific T-cell printing in mice lacking CD40 ligand. Nature, 1995. 378(6557): p. 617-620.
133. van Essen, D., H. Kikutani, and D. Gray, CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature, 1995. 378(6557): p. 620-623.
134. Ranheim, E.A. and T.J. Kipps, Activated T cells induce expression of B7/ BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med, 1993. 177(4): p. 925-935.
135. Roy, M., et al., Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol, 1995. 25(2): p. 596-603.
136. de Boer, M., et al., Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur J Immunol, 1993. 23(12): p. 3120-3125.
137. Linsley, P.S., et al., Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity, 1994. 1(9): p. 793-801.
138. Damle, N.K., et al., Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol, 1994. 152(6): p. 2686-2697.
139. Hutloff, A., et al., ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature, 1999. 397(6716): p. 263-266.
140. Yoshinaga, S.K., et al., T-cell co-stimulation through B7RP-1 and ICOS. Nature, 1999. 402(6763): p. 827-832.
141. Mages, H.W, et al., Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol, 2000. 30(4): p. 1040-1047.
142. Hang, L., E.M. Porter, and W.C. Sha, Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J Exp Med, 2002. 196(1): p. 197-108.
143. Dong, C., et al., ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature, 2001. 409(6816): p. 97-101.
144. McAdam, A.J., et al., ICOS is critical for CD40-mediated antibody class switching. Nature, 2001. 409(6816): p. 102-105.
145. Tafuri, A., et al., ICOS is essential for effective T-helper-cell responses. Nature, 2001. 409(6816): p. 105-109.
146. Mak, T.W, et al, Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat Immunol, 2003. 4(8): p. 765-772.
147. Duddy, M.E., A. Alter, and A. Bar-Or, Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol, 2004. 172(6): p. 3422-3427.
148. Kawai, T. and S. Akira, Pathogen recognition with Toll-like receptors. Curr Opin Immunol, 2005. 17(4): p. 338-344.
149. Pasare, C. and R. Medzhitov, Control of B-cell responses by Toll-like receptors. Nature, 2005. 438(7066): p. 364-368.
150. Fillatreau, S. and R.A. Manz, Tolls for B cells. Eur J Immunol, 2006. 36(4): p. 798-801.
151. Bourke, E., et al., The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood, 2003. 102(3): p. 956-963.
152. Bernasconi, N.L, N. Onai, and A. Lanzavecchia, A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 2003. 101(1 1): p. 4500-4504.
153. Hartmann, G. and A.M. Krieg, Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol, 2000. 164(2): p. 944-953.
154. Jahrsdorfer, B., et al., CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol, 2001. 69(1): p. 81-88.
155. Ruprecht, C.R. and A. Lapzavecchia, Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol, 2006. 36(4): p. 810-816.
156. Mosier, D.E., J.J. Mond, and E.A. Goldings, The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol, 1977. 119(6): p. 1874-1878.
157. Mosier, D.E., et al., Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J Infect Dis, 1977. 136 Suppl: p. S14-19.
158. Kearney, J.F. and A.R. Lawton, B lymphocyte differentiation induced by lipopolysaccharide. I. Generation of cells synthesizing four major immunoglobulin classes. J Immunol, 1975. 115(3): p. 671-676.
159. Miyake, K., et al., Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/IMD-1. J Endotoxin Res, 2000. 6(5): p. 389-391.
160. Gronowicz, E. and A. Coutinho, Selective triggering of B cell subpopulations by mitogens. Eur J Immunol, 1974. 4(11): p. 771-776.
161. Constant, S., et al., B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol, 1995. 155(8): p. 3734-3741.
162. Rodriguez-Pinto, D. and J. Moreno, B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner. Eur J Immunol, 2005. 35(4): p. 1097-1105.
163. Batista, F.D. and M.S. Neuberger, B cells extract and present immobilized antigen: implications for affinity discrimination. Embo J, 2000. 19(4): p. 513-520.
164. Guermonprez, P., et al., The rate of dissociation between antibody and antigen determines the efficiency of antibody-mediated antigen presentation to T cells. J Immunol, 1998. 161(9): p. 4542-4548.
165. Lanzavecchia, A., Antigen-specific interaction between T and B cells. Nature, 1985. 314(6011): p. 537-539.
166. Batista, F.D. and M.S. Neuberger, Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity, 1998. 8(6): p. 751-759.
167. Rivera, A., et al., Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol, 2001. 13(12): p. 1583-1593.
168. Nashar, T.O. and J.R. Drake, The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation. J Immunol, 2005. 174(3): p. 1306-1316.
169. Wardemann, H., et al., Predominant autoantibody production by early human B cell precursors. Science, 2003. 301(5638): p. 1374-1377.
170. Nemazee, D.A. and K. Burki, Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature, 1989. 337 (6207): p. 562-566.
171. Cyster, J.G., S.B. Hartley, and C.C. Goodnow, Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature, 1994. 371(6496): p. 389-395.
172. Nossal, G.J. and B.L. Pike, Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci U S A, 1980. 77(3): p. 1602-1606.
173. Cyster, J.G. and C.C. Goodnow, Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity, 1995. 3(6): p. 691-701.
174. Rojas, M., C. Hulbert, and J.W. Thomas, Anergy and not clonal ignorance determines the fate of B cells that recognize a physiological autoantigen. J Immunol, 2001. 166(5): p. 3194-3200
175. Halverson, R., R.M. Torres, and R. Pelanda, Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol, 2004. 5(6): p. 645-650.
176. Gay, D., et al., Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993. 177(4): p. 999-1008.
177. Tiegs, S.L., D.M. Russell, and D. Nemazee, Receptor editing in self-reactive bone marrow B cells. J Exp Med, 1993. 177(4): p. 1009-1020.
178. Radic, M.Z., et al., B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med, 1993. 177(4): p. 1165-1173.
179. Chen, C., et al., Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity, 1995. 3(6): p. 747-755.
180. Hartley, S.B., et al., Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell, 1993. 72(3): p. 325-335.
181. Casellas, R., et al., Contribution of receptor editing to the antibody repertoire. Science, 2001. 291(5508): p. 1541-1544.
182. Nikolaisen, C., O.P. Rekvig, and H.C. Nossent, Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. Scand J Rheumatol, 2005. 34(4): p. 269-276.
183. Cambridge, G., et al., Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum, 2006. 54(3): p. 723-732.
184. Simon, J.A., et al., Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford), 2004. 43(2): p. 220-224.
185. Braun, A., et al., Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol, 2007. 36(4): p. 291-298.
186. Sims, G.P., et al., Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol, 2001. 167(4): p. 1935-1944.
187. Hamidpour M., et al., The isolation and characterisation of antiplatelet antibodies. Eur J Haematol, 2006. 76(4): p. 331-338.
188. Sikorska, A., L. Konopka, and K. Maslanka, The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura. Int J Lab Hematol, 2008. 30(1): p. 58-64.
189. Kalled, S.L., et al., Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol, 1998. 160(5): p. 2158-2165.
190. De Jong, Y.P., et al., Chronic murine colitis is dependent on the CD154/ CD40 pathway and can be attenuated by anti-CD154 administration.
191. Krzysiek, R., et al., Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J Immunol, 1999. 162(8): p. 4455-4463.
192. Kaser, A., et al., B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol, 2000. 165(5): p. 2474-2480.
193. Takemura, S., et al., Lymphoid neogenesis in rheumatoid synovitis. J Immunol, 2001. 167(2): p. 1072-1080.
194. Shi, K., et al., Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol, 2001. 166(1): p. 650-655.
195. Groom, J., et al., Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest, 2002. 109(1): p. 59-68.
196. Corcione, A., et al., Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A, 2004. 101(30): p. 11064-11069.
197. Serafini, B., et al., Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol, 2004. 14(2): p. 164-174.
198. Armengol, M.P., et al., Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in
199. Aust, G., et al., The role of CXCR5 and its ligand CX-CL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur J Endocrinol, 2004. 150(2): p. 225-234.
200. Peterson, K.S., et al., Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest, 2004. 113(12): p. 1722-1733.
201. Gonzalez, M., et al., The sequential role of lymphotoxin and B cells in the development of splenic follicles. J Exp Med, 1998. 187(7): p. 997-1007.
202. O'Keefe, T.L., et al., Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med, 1999. 189(8): p. 1307-1313.
203. Inaoki, M., et al., CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med, 1997. 186(11): p. 1923-1931.
204. Sato, S., et al., Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol, 2000. 165(11): p. 6635-6643.
205. Weintraub, J.P., et al., Immunological and pathological consequences of mutations in both Fas and Fas ligand. Cell Immunol, 1998. 186(1): p. 8-17.
206. Zhang, Y., et al., A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas (lprcg) mice. Clin Exp Immunol, 2000. 122(1):p.124-132.
207. Mackay F. and C.R. Mackay, The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol, 2002. 23(3): p. 113-115.
208. Groom, J.R., et al., BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med, 2007. 204(8): p. 1959-1971.
209. Cheema, G.S., et al., Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum, 2001. 44(6): p. 1313-1319.
210. Zhang, J., et al., Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol, 2001. 166(1): p. 6-10.
211. Emmerich, E, et al., High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol, 2007. 136(2): p. 309-314.
212. Cambridge, G., et al., Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum, 2003. 48(8): p. 2146-2154.
213. Stasi, R., et al., Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood, 2002. 99(10): p. 3872-3873.
214. Leandro, M.J., et al., An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum, 2002. 46(10): p. 2673-2677.
215. Leandro, M.J., et al., B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford), 2005. 44(12): p. 1542-1545.
216. Shlomchik, M.J., et al., The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med, 1994. 180(4): p. 1295-1306.